A Randomized Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Bivalent RSVpreF Vaccine in Older Adults in Korea.
- DOI
- 10.3390/vaccines14090773
- Published
- 2026 Sep 3
- Container
- Vaccines
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/vaccines14090773,
title = {A Randomized Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Bivalent RSVpreF Vaccine in Older Adults in Korea.},
author = {Choi WS and Quan K and Baber JA and Jaques A and van Rensburg KJ and Li W and Cutler MW and Kalinina EV and Anderson AS and Swanson KA and Gurtman A and Munjal I and Jeongwol C3671053 Clinical Trial Group},
year = {2026},
journal = {Vaccines},
doi = {10.3390/vaccines14090773},
url = {https://doi.org/10.3390/vaccines14090773}
}RIS
TY - JOUR TI - A Randomized Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Bivalent RSVpreF Vaccine in Older Adults in Korea. AU - Choi WS AU - Quan K AU - Baber JA AU - Jaques A AU - van Rensburg KJ AU - Li W AU - Cutler MW AU - Kalinina EV AU - Anderson AS AU - Swanson KA AU - Gurtman A AU - Munjal I AU - Jeongwol C3671053 Clinical Trial Group PY - 2026 JO - Vaccines DO - 10.3390/vaccines14090773 UR - https://doi.org/10.3390/vaccines14090773 ER -
APA
WS, C., K, Q., JA, B., A, J., KJ, V. R., W, L., MW, C., EV, K., AS, A., KA, S., A, G., I, M., & Group, J. C. C. T. (2026). A Randomized Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Bivalent RSVpreF Vaccine in Older Adults in Korea.. Vaccines. https://doi.org/10.3390/vaccines14090773
Source records
- pubmed · retrieved 2026-09-26T11:00:38.226Z